Table 1 |
|||||
|
Origins of a number of commonly used breast cancer cell lines and their citation frequency from 1 January 1990 to 31 December2002, according to PubMed |
|||||
|
Cell line |
Origin |
Age (years) |
Pathology |
Citations |
Reference |
|
|
|||||
|
BT20 |
Breast |
74 |
Invasive ductal carcinoma |
260 |
[9] |
|
MDA-MB-231 |
Pleural effusion |
51 |
Adenocarcinoma |
1157 |
|
|
MDA-MB-435 |
Pleural effusion |
31 |
Invasive ductal carcinoma |
292 |
[11] |
|
MDA-MB-468 |
Pleural effusion |
51 |
Adenocarcinoma |
223 |
[11] |
|
MCF-7 |
Pleural effusion |
69 |
Invasive ductal carcinoma |
5774 |
[8] |
|
SkBr3 |
Pleural effusion |
43 |
Adenocarcinoma |
203 |
[12] |
|
T47D |
Pleural Effusion |
54 |
Invasive ductal carcinoma |
866 |
[13] |
|
ZR75.1 |
Ascites |
47 |
Invasive ductal carcinoma |
590 |
[14] |
|
|
|||||
|
Burdall et al. Breast Cancer Res 2003 5:89 doi:10.1186/bcr577 |
|||||